Beyond Health Resource Article:

Why We Don't Sell Supplements or Endorse Products

Why We Don't Sell Supplements or Endorse Products Image

By Dr. Steven Long, DO, MS-HSA, NASM-CPT, PBC
Beyond Health | Precision Medicine for High-Performance Living

In modern healthcare, it has become increasingly common for clinics, influencers, and even physicians to sell supplements, devices, and branded products directly to patients.

Sometimes this is framed as convenience.
Sometimes as “curation.”
Sometimes as a way to ensure quality.

At Beyond Health, we’ve made a deliberate and uncommon choice:

We do not sell supplements.
We do not endorse products.
We do not receive commissions, kickbacks, or affiliate revenue.

This is not an oversight.
It is a core part of our clinical philosophy.

1. Financial Incentives Change Clinical Judgment—Even When Intentions Are Good

There is a large body of literature demonstrating that financial conflicts of interest influence medical decision-making, often unconsciously.

Physicians consistently underestimate how incentives affect their own recommendations while recognizing the effect in others.

A systematic review by Bekelman et al. (2003) showed that financial relationships between physicians and industry were associated with changes in prescribing behavior, research outcomes, and clinical recommendations.

Importantly, these effects were not limited to overt misconduct. They occurred even when clinicians believed they were acting objectively.

Selling a product—any product—creates an incentive structure.

We believe medicine should be insulated from that pressure as much as possible.

2. Supplements Blur the Line Between Care and Commerce

When a clinician both recommends and sells a product, the relationship changes.

Patients are no longer just asking, “Is this good for me?”
 They are implicitly asking, “Is this good for me—or good for your business?”

Even when the recommendation is reasonable, trust is diluted.

We want patients to know that when we recommend an intervention, it is because:

  • The evidence supports it
  • The physiology makes sense
  • It fits their goals and risk profile

Not because it appears on our shelf.

3. The Evidence for Most Supplements Is Modest at Best

While some supplements have narrow, evidence-supported use cases, the majority do not meaningfully change long-term clinical outcomes.

Systematic reviews repeatedly show that many commonly marketed supplements:

  • Have small effect sizes
  • Rely on surrogate endpoints
  • Are supported by short-term or industry-funded trials
  • Fail to replicate benefits in larger, independent studies

Bjelakovic et al. (2012) demonstrated that antioxidant supplementation did not reduce—and in some cases increased—all-cause mortality, despite strong mechanistic rationale.

Supplements often promise far more than they deliver.

Selling them risks overselling certainty that does not exist.

4. Supplements Are Not Harmless Just Because They Are Optional

Another common misconception is that supplements are “low risk,” so selling them is benign.

In reality:

  • Supplements are not required to prove efficacy
  • Quality and dosing are inconsistent
  • Contamination and mislabeling are well documented
  • Adverse effects are underreported

Navarro et al. (2017) identified dietary supplements as a growing cause of acute liver injury in the United States.

When a clinic sells supplements, it implicitly vouches for their safety—often without the data to support that assurance.

We take that responsibility seriously.

5. We Don’t Want Your Progress to Depend on Purchases

One of the most subtle harms of product-based medicine is dependency.

Patients begin to believe that progress requires:

  • The right powder
  • The right pill
  • The right brand

This shifts focus away from what actually drives outcomes:

  • Strength training
  • Aerobic fitness
  • Sleep
  • Nutrition quality
  • Metabolic health
  • Consistency over time

We want patients to understand that their health is built by behavior and physiology—not by shopping decisions.

6. Education Scales Better Than Products

Selling supplements can feel efficient. Education is harder.

But education scales in a way products never will.

When patients understand:

  • Why muscle improves insulin sensitivity
  • Why visceral fat matters more than weight
  • Why sleep affects cognition and metabolism
  • Why strength predicts independence

They can make informed decisions anywhere, at any time, without needing us to sell them something.

That is real empowerment.

7. What We Do Instead

We focus on:

  • Evidence-based guidance
  • Transparent discussion of benefits and limitations
  • Prioritization of high-impact interventions
  • Referrals to third-party testing when appropriate
  • Avoidance of brand allegiance

If a supplement may be reasonable in a specific context, we discuss:

  • The evidence
  • The uncertainty
  • The potential risks
  • How to evaluate quality independently

Then the patient decides—without financial pressure from us.

8. This Is Harder—and Intentional

Not selling supplements is not the easy path.

It means:

  • Saying no to revenue streams
  • Spending more time educating
  • Accepting slower, less flashy growth
  • Standing apart from trends

But it also means preserving the one thing that matters most in medicine:

Trust.

9. The Beyond Health Perspective

At Beyond Health, we believe medicine works best when:

  • Advice is unbiased
  • Incentives are aligned with outcomes
  • Patients are treated as partners, not customers

Our role is to guide, interpret, and apply science—not to monetize shelves.

If something truly improves healthspan, it should stand on evidence—not endorsement.

Bottom Line

We don’t sell supplements or endorse products because:

  • Financial incentives distort judgment
  • Evidence is often weaker than marketing suggests
  • Trust matters more than convenience
  • Health is built through physiology, not purchases

We are here to help you build strength, resilience, and independence—not a shopping cart.

Bibliography

  1. Bekelman JE, et al. “Scope and impact of financial conflicts of interest in biomedical research.” JAMA. 2003.
  2. Bjelakovic G, et al. “Antioxidant supplements for prevention of mortality.” Cochrane Database of Systematic Reviews. 2012.
  3. Navarro VJ, et al. “Liver injury from herbal and dietary supplements.” New England Journal of Medicine. 2017.
  4. Lo B, Field MJ. Conflict of Interest in Medical Research, Education, and Practice. National Academies Press. 2009.
  5. Cohen PA. “The supplement paradox.” New England Journal of Medicine. 2016.

Get Started Today

Contact Beyond Health today and take the first step toward a vibrant, healthier lifestyle!